Association between standardized uptake value and survival in patients with locally advanced or metastatic squamous cell head and neck cancer

Association between standardized uptake value and survival in patients with locally advanced or metastatic squamous cell head and neck cancer

Introduction and objective: The present study aimed to evaluate the association between tumor Standard Uptake Value (SUVmax) values obtained by PET/CT, and survival in patients with locally advanced or metastatic squamous cell head and neck cancer. Method: The present study included 38 patients with...

Full description

Bibliographic Details
Main Authors:	Zeynep Oruc, M. Emin Buyukbayram, Muhammet Ali Kaplan, Zuhat Urakcı, Mehmet Küçüköner, Abdurrahman Isıkdogan
Format:	Article
Language:	English
Published:	Turkiye Klinikleri 2016-01-01
Series:	Journal of Oncological Sciences
Subjects:	Standard uptake value PET CT Head and neck cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452336415000047

Similar Items

Effects of educational status and the living environment on the prognosis of head and neck squamous cell carcinoma
by: Zeynep Oruç, et al.
Published: (2016-08-01)

A metastatic malign melanoma case with diffuse cutaneous melanosis
by: Zeynep Oruç, et al.
Published: (2016-08-01)

Evaluation of Factors Predicting the Effectiveness of Regorafenib in the Treatment of Metastatic Colorectal Cancer
by: Senar Ebinç, et al.
Published: (2022-10-01)

Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices
by: Senar Ebinç, et al.
Published: (2023-09-01)

Advanced diagnostic techniques of metastatic neck lymph nodes
by: Maja Jocić, et al.
Published: (2013-12-01)

Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma
by: Maurice C. Cox, et al.
Published: (2023-10-01)

The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
by: Hoshino Terada, et al.
Published: (2021-04-01)

Importance of PET/CT in Initial Workup of Head and Neck Squamous Cell Carcinoma
by: Ryan N. Hellums, et al.
Published: (2023-07-01)

The role of imaging in head and neck cancer: An overview of different imaging modalities in primary diagnosis and staging of the disease
by: Veena Vishwanath, et al.
Published: (2020-10-01)

Detection of distant metastases and distant second primary cancers in head and neck squamous cell carcinoma: comparison of [18F]FDG PET/MRI and [18F]FDG PET/CT
by: Eirini Katirtzidou, et al.
Published: (2022-07-01)

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
by: Panagiota Economopoulou, et al.
Published: (2019-08-01)

Development of a Model Based on Delta-Radiomic Features for the Optimization of Head and Neck Squamous Cell Carcinoma Patient Treatment
by: Severina Šedienė, et al.
Published: (2023-06-01)

Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation
by: Austin J. Iovoli, et al.
Published: (2021-03-01)

Clinical Utility of Second-Look FDG PET-CT to Stratify Incomplete Metabolic Response Post (Chemo) Radiotherapy in Oropharyngeal Squamous Cell Carcinoma
by: Sarah Billingsley, et al.
Published: (2023-01-01)

Early [18]FDG PET/CT scan predicts tumor response in head and neck squamous cell cancer patients treated with erlotinib adjusted per smoking status
by: Mercedes Porosnicu, et al.
Published: (2022-08-01)

Complementary Value of Intra- and Peri-Tumoral PET/CT Radiomics for Outcome Prediction in Head and Neck Cancer
by: Wenbing Lv, et al.
Published: (2021-01-01)

Neck Dissection for Cervical Lymph Node Metastases from Remote Primary Malignancies
by: Shogo Shinohara, et al.
Published: (2020-07-01)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
by: Katie eNewbold, et al.
Published: (2012-12-01)

Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma
by: C. Pisani, et al.
Published: (2021-03-01)

Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
by: Tim Van den Wyngaert, et al.
Published: (2020-08-01)

Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer
by: Bingzhen Wang, et al.
Published: (2023-02-01)

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
by: Miren Taberna, et al.
Published: (2019-05-01)

Context-Aware Saliency Guided Radiomics: Application to Prediction of Outcome and HPV-Status from Multi-Center PET/CT Images of Head and Neck Cancer
by: Wenbing Lv, et al.
Published: (2022-03-01)

Value of Dedicated Head and Neck 18F-FDG PET/CT Protocol in Detecting Recurrent and Metastatic Lesions in Post-surgical Differentiated Thyroid Carcinoma Patients with High Serum Thyroglobulin Level and Negative 131I Whole-body Scan
by: Mai Hong Son, et al.
Published: (2016-01-01)

Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI
by: Christian Martin Meerwein, et al.
Published: (2015-02-01)

Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx
by: Mindaugas Grybauskas, et al.
Published: (2014-01-01)

Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck
by: Schmitz Sandra, et al.
Published: (2015-03-01)

Lipid metabolism marker CD36 is associated with 18FDG-PET/CT false negative lymph nodes in head and neck squamous cell carcinoma
by: Xiaoyan Meng, et al.
Published: (2023-05-01)

Neck management in metastatic cutaneous squamous cell carcinoma of the head and neck
by: Ning Xu, et al.
Published: (2024-02-01)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
by: Ammar Sukari, et al.
Published: (2015-04-01)

Early post-treatment 18F-FDG PET/CT for predicting radiation-induced hypothyroidism in head and neck cancer
by: Hsi-Huei Lu, et al.
Published: (2022-10-01)

The current role of imaging in head and neck cancer: a clinician’s perspective
by: Michael F Schlumpf, et al.
Published: (2014-09-01)

Assessment of head and neck-imaging reporting and data system using fluro-deoxy-glucose-positron emission tomography/computerized tomography scan imaging of recurrence of head and neck tumors
by: Mohamed AbdelAziz Abo Shanab, et al.
Published: (2023-05-01)

Integration of 18-FDG PET/CT in the Initial Work-Up to Stage Head and Neck Cancer: Prognostic Significance and Impact on Therapeutic Decision Making
by: Jean-Christophe Leclere, et al.
Published: (2020-06-01)

Comparable Accuracy of Quantitative and Visual Analyses of [<sup>18</sup>F]FDG PET/CT for the Detection of Lymph Node Metastases from Head and Neck Squamous Cell Carcinoma
by: Philippe d’Abadie, et al.
Published: (2023-08-01)

Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience
by: Marco Rubatto, et al.
Published: (2023-01-01)

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
by: Ji Hyun Lee, et al.
Published: (2021-10-01)

High-Resolution <sup>18</sup>F-FDG PET/CT for Assessing Three-Dimensional Intraoperative Margins Status in Malignancies of the Head and Neck, a Proof-of-Concept
by: Jens M. Debacker, et al.
Published: (2021-08-01)

Primary thyroid hemangioma, a rare diagnosis in a patient with a painless neck mass
by: Joey Seuferling, BS, et al.
Published: (2023-02-01)

Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer
by: Beat Bojaxhiu, et al.
Published: (2022-08-01)